Exploring Genetic Risk and Immunotherapy Side Effects in Lung Cancer

This chapter explores the interplay between genetic research and immunotherapy for lung cancer, emphasizing the risk of colitis as a side effect. The discussion includes the creation of a polygenic risk score to identify patients with a predisposition to colitis, while also noting that these patients can still have favorable outcomes with immunotherapy.